LIVE, ONE-HOUR FUNDRAISING EVENT TO AIR SIMULTANEOUSLY ON ABC, CBS, FOX, NBC AND 26 BROADCAST AND CABLE NETWORKS 8 PM ET & PT / 7PM CT Broadcast Coincides with Live Stand Up To Cancer Canada Event, with Canadian-Inclusive Telecast for Canadian Audience July 9, 2014 (Los Angeles / New York) – Building on three historic … Continued
(July 8, 2014) Frequent mutations in the ARID1A gene have been previously discovered in ovarian endometrioid and clear-cell cancers. Now research supported by OCRF has provided direct evidence that it is an authentic tumor suppressor gene using a mouse model. OCRF Ann Schreiber Mentored Investigator grantee Bin Guan, PhD is first author, and OCRF Scientific … Continued
WORLD FAMOUS DESIGNER GARAGE SALE SPONSORED BY QVC SATURDAY, JULY 26TH IN WATERMILL, NY NEW YORK, N.Y. – July 8, 2014 – Kelly Ripa and Donna Karan will host Ovarian Cancer Research Fund’s (OCRF) 17th annual Super Saturday, sponsored by QVC. Super Saturday 17 will take place on Saturday, July 26, 2014, at Nova’s Ark … Continued
Q&A with John Weroha, MD, PhD 2014 Liz Tilberis Early Career Award Mayo Clinic Were you always in interested in science? By the time I was in high school I knew I wanted to have a career in biology, but I think my interest actually started earlier. When … Continued
(July 1, 2014) There is “little evidence” that the use of conventional fertility hormones used for ovarian stimulation in the treatment of infertility increases the long-term risk of breast and gynecological cancers, according to the results of a significant 30-year follow-up study. However, the extended use of clomiphene citrate was associated with a higher risk … Continued
The American College of Physicians recently recommended that women do not need to have a pelvic exam on an annual basis. Current evidence suggests that the pelvic exam is not helpful as a routine screening test for women with an average risk of developing ovarian cancer.
2015 marks the 15th anniversary of the Wisconsin Ovarian Cancer Alliance (WOCA), a Partner Member organization dedicated to overcoming ovarian cancer through education, advocacy, and awareness. When oncology nurse Joan Sagan was diagnosed with stage 3C ovarian cancer in 1999, she, along with sisters Kelli Zembruski and Sandi Wagner, realized there was an immediate need for ovarian cancer education in their home state of Wisconsin. While Joan knew from her role as an oncology nurse how devastating this disease can be, Kelli and Sandi knew very little about ovarian cancer. At this point, ovarian cancer was still known as the silent killer, with no symptom awareness. In May 2000, the Wisconsin Ovarian Cancer Alliance was officially founded, with the mission to educate the community about ovarian cancer and raise awareness about this horrible disease. Click the plus sign to read more.
(June 25, 2014) Research presented at the annual meeting of the American Society of Clinical Oncology earlier this month suggests that palliative care delivered at the time of cancer diagnosis improves survival. A randomized trial of palliative oncology care in 207 patients with advanced cancer and their caregivers showed that the risk of death at … Continued
(June 24, 2014) Earlier this month, researchers reported results of a Phase II trial which looked at efficacy and safety of a biweekly gemcitabine, carboplatin, and bevacizumab combination in patients with platinum-sensitive recurrent ovarian, peritoneal, or tubal cancer. The results, which were published online June 5, 2014 in the journal Gynecologic Oncology, showed that biweekly … Continued
On Monday, June 16, 2014, Dr. Douglas Levine of Memorial Sloan Kettering Cancer Center presented a free webinar focusing on research news that was presented at 2014’s medical meetings. In his hour-long presentation, he focused primarily on new ovarian cancer research that was presented at the American Society of Clinical Oncology’s annual meeting, which took … Continued
Promising new combination treatments for ovarian cancer Dr. Joyce Liu, MD, on behalf of researchers from the National Cancer Institute (NCI) and Dana Farber Cancer Institute (DFCI), presented striking results from a Phase II trial testing the combination of the PARP inhibitor olaparib and the anti-angiogenesis drug cediranib (which blocks tumors from creating new blood … Continued
Kelly Ripa Stars in Public Service Announcements for “QVC Presents Super Saturday LIVE,” Benefitting Ovarian Cancer Research Fund WEST CHESTER, Pa. (June 10, 2014) – Kelly Ripa is shopping to save lives as she fills up her bag with designer deals that will contribute to the cure for ovarian cancer. Ripa, one of the most … Continued
Get email updates about research news, action alerts, and ways to join the fight.
